Explore All 2731 Add-on Acquisition Medical Products Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | February 19, 2013 |
| Target | Nfocus Neuromedical |
| Sector | Medical Products |
| Buyer(s) | Covidien |
| Deal Type | Add-on Acquisition |
| Deal Value | 72M USD |
FILTER BY
| Category | Company |
|---|---|
| Sector | Medical Products |
| Employees | 38,500 |
| Revenue | 10.2B USD (2013) |
Covidien plc is a global healthcare technology and medical supplies provider. Covidien was formed as a spin-off from Tyco in 2007 and is based in Dublin, Ireland.
| Deal Context for Buyer | # |
|---|---|
| Overall | 18 of 21 |
| Sector: Medical Products | 13 of 15 |
| Type: Add-on Acquisition | 14 of 17 |
| State: California | 7 of 8 |
| Country: United States | 14 of 16 |
| Year: 2013 | 1 of 2 |
| Size (of disclosed) | 14 of 14 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-12-26 |
CV Ingenuity
Fremont, California, United States CV Ingenuity is a privately-held company focused on improving patient outcomes in the treatment of peripheral arterial disease (PAD) by providing solutions to relieve vascular obstructions, inhibit restenosis, and allow natural vessel healing. The company's core technology, while still in the investigational phase, is a Drug Coated Balloon (DCB) platform with a novel, proprietary, tunable, rapid-release system. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-06-28 |
Mallinckrodt
Dublin, United Kingdom Mallinckrodt is a specialty pharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company’s core strengths include the acquisition and management of highly regulated raw materials; deep regulatory expertise; and specialized chemistry, formulation and manufacturing capabilities. Mallinckrodt was founded in 1867 and is based in Dublin, Ireland. |
Sell | - |
